Advanced Cell Technology gets 2 patents related to retinal cells

09/15/2010 | Mass High Tech (Boston)

Advanced Cell Technology has received a patent to use retinal pigment epithelial cells derived from human embryonic stem cells in the treatment of retinal degeneration. The company also received another patent that allows it to produce RPE cells for use in transplantation. The patents will enable the company to test its cell treatment for Stargardt's disease.

View Full Article in:

Mass High Tech (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR